{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:15:51Z","timestamp":1789038951299,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872189"],"award-info":[{"award-number":["81872189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR60107"],"award-info":[{"award-number":["SHDC2020CR60107"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pain is the most frequent complication in patients with oral squamous cell carcinoma (OSCC) and is associated with poor prognosis. Calcitonin gene\u2013related peptide (CGRP), abundantly expressed in sensory neurons, has been implicated in multiple pain disorders; however, its role in cancer-associated pain remains unclear. We investigated the relationship between CGRP and OSCC-associated pain and evaluated the analgesic potential of Rimegepant, a CGRP-receptor antagonist approved for migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma CGRP was measured in OSCC patients and correlated with preoperative pain scores and clinical outcomes over a 30-month follow-up. Immunohistochemistry quantified CGRP within tumor-infiltrating nerve fibers. In a unilateral orthotopic tongue OSCC mouse model, we compared the analgesic effects of Rimegepant with carprofen and tramadol. RNA-sequencing of ipsilateral trigeminal ganglia from treated mice was performed to explore potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma CGRP levels were positively correlated with patient-reported pain severity and were associated with reduced overall survival. Increased CGRP expression in tumor-infiltrating nerves was linked to greater pain intensity and lymph node metastasis. In an OSCC mouse model, both systemic and local administration of Rimegepant significantly attenuated facial mechanical hypersensitivity. Transcriptomic analysis of trigeminal ganglia, together with RT\u2013qPCR validation, revealed suppression of innate immune and neuroinflammatory pathways following Rimegepant treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings link sensory-nerve-derived CGRP to OSCC-associated pain and support further evaluation of CGRP receptor antagonism as a potential analgesic strategy in cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-026-08444-x","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:09:53Z","timestamp":1777432193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting CGRP signaling alleviates cancer-associated pain in oral squamous cell carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Mingtao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"8444_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1526-4637.2006.00220.x","volume":"8","author":"AW Burton","year":"2007","unstructured":"Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8:189\u201398.","journal-title":"Pain Med"},{"key":"8444_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jpain.2014.07.003","volume":"15","author":"CC Reyes-Gibby","year":"2014","unstructured":"Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain. 2014;15:1015\u201322.","journal-title":"J Pain"},{"key":"8444_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1523\/JNEUROSCI.1211-20.2020","volume":"41","author":"NH Tu","year":"2021","unstructured":"Tu NH, Jensen DD, Anderson BM, Chen E, Jimenez-Vargas NN, Scheff NN, et al. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2. J Neurosci. 2021;41:193\u2013210.","journal-title":"J Neurosci"},{"key":"8444_CR4","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol. 2018;29:iv166\u201391.","journal-title":"Ann Oncol"},{"key":"8444_CR5","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/cncr.31303","volume":"124","author":"JA Paice","year":"2018","unstructured":"Paice JA. Cancer pain management and the opioid crisis in America: how to preserve hard-earned gains in improving the quality of cancer pain management. Cancer. 2018;124:2491\u20137.","journal-title":"Cancer"},{"key":"8444_CR6","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/annonc\/mdw407","volume":"27","author":"P Sj\u00f8gren","year":"2016","unstructured":"Sj\u00f8gren P, Kaasa S. The role of opioids in cancer progression: emerging experimental and clinical implications. Ann Oncol. 2016;27:1978\u201380.","journal-title":"Ann Oncol"},{"key":"8444_CR7","doi-asserted-by":"publisher","unstructured":"Gysler SM, Drapkin R. Tumor innervation: peripheral nerves take control of the tumor microenvironment. J Clin Invest. 2021;131(11):e147276. https:\/\/doi.org\/10.1172\/JCI147276.","DOI":"10.1172\/JCI147276"},{"key":"8444_CR8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.trecan.2020.07.005","volume":"6","author":"HD Reavis","year":"2020","unstructured":"Reavis HD, Chen HI, Drapkin R. Tumor innervation: cancer has some nerve. Trends Cancer. 2020;6:1059\u201367.","journal-title":"Trends Cancer"},{"key":"8444_CR9","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cmet.2022.10.012","volume":"34","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin C, Liu Z, Sun Y, Chen M, Guo Y, et al. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metab. 2022;34:1999-2017.e10.","journal-title":"Cell Metab"},{"key":"8444_CR10","doi-asserted-by":"publisher","unstructured":"Zhang Y, Guo Y, Liu Z, Sun Y, Yang X, Chen M, et al. Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance. Cell. 2025;188(24):6754\u20136773.e29. https:\/\/doi.org\/10.1016\/j.cell.2025.09.029.","DOI":"10.1016\/j.cell.2025.09.029"},{"key":"8444_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94:1099\u2013142.","journal-title":"Physiol Rev"},{"key":"8444_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol. 2018;14:338\u201350.","journal-title":"Nat Rev Neurol"},{"key":"8444_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","volume":"381","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, et al. Rimegepant, an oral Calcitonin Gene-Related Peptide Receptor Antagonist, for migraine. N Engl J Med. 2019;381:142\u20139.","journal-title":"N Engl J Med"},{"key":"8444_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40265-020-01301-3","volume":"80","author":"LJ Scott","year":"2020","unstructured":"Scott LJ. Rimegepant: first approval. Drugs. 2020;80:741\u20136.","journal-title":"Drugs"},{"key":"8444_CR15","first-page":"1","volume":"9","author":"SH Chen","year":"2019","unstructured":"Chen SH, Zhang BY, Zhou B, Zhu CZ, Sun LQ, Feng YJ. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. Am J Cancer Res. 2019;9:1\u201321.","journal-title":"Am J Cancer Res"},{"key":"8444_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55\u201363.","journal-title":"J Neurosci Methods"},{"key":"8444_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jpain.2012.02.009","volume":"13","author":"C Mills","year":"2012","unstructured":"Mills C, Leblond D, Joshi S, Zhu C, Hsieh G, Jacobson P, et al. Estimating efficacy and drug ED50\u2019s using von Frey thresholds: impact of Weber\u2019s law and log transformation. J Pain. 2012;13:519\u201323.","journal-title":"J Pain"},{"key":"8444_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/00220345221088527","volume":"101","author":"Y Ye","year":"2022","unstructured":"Ye Y, Jensen DD, Viet CT, Pan HL, Campana WM, Amit M, et al. Advances in Head and Neck Cancer Pain. J Dent Res. 2022;101:1025\u201333.","journal-title":"J Dent Res"},{"key":"8444_CR19","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1136\/bmj.p2104","volume":"382","author":"G Iacobucci","year":"2023","unstructured":"Iacobucci G. NICE recommends rimegepant for treating acute migraine in adults. BMJ. 2023;382:2104.","journal-title":"BMJ"},{"key":"8444_CR20","doi-asserted-by":"publisher","first-page":"10644","DOI":"10.1021\/jm3013147","volume":"55","author":"G Luo","year":"2012","unstructured":"Luo G, Chen L, Conway CM, Denton R, Keavy D, Signor L, et al. Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral Calcitonin Gene-Related Peptide (CGRP) antagonist in clinical trials for treating migraine. J Med Chem. 2012;55:10644\u201351.","journal-title":"J Med Chem"},{"key":"8444_CR21","doi-asserted-by":"publisher","first-page":"123757","DOI":"10.1016\/j.biomaterials.2025.123757","volume":"327","author":"CJ Peach","year":"2026","unstructured":"Peach CJ, Tu NH, Lewis PK, Pollard RE, Sokrat B, Nicholson S, et al. Nanoparticle-mediated antagonism of sustained endosomal signaling of the Calcitonin Receptor-Like Receptor provides enhanced and persistent relief of oral cancer pain. Biomaterials. 2026;327:123757.","journal-title":"Biomaterials"},{"key":"8444_CR22","doi-asserted-by":"publisher","unstructured":"Tu NH, Inoue K, Lewis PK, Khan A, Hwang JH, Chokshi V, et al. Calcitonin Related Polypeptide Alpha Mediates Oral Cancer Pain. Cells. 2023;12(13):1675. https:\/\/doi.org\/10.3390\/cells12131675.","DOI":"10.3390\/cells12131675"},{"key":"8444_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1186\/s12885-021-08998-9","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chen M, Liu Z, Wang X, Ji T. The neuropeptide Calcitonin Gene-Related Peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma. BMC Cancer. 2021;21:1254.","journal-title":"BMC Cancer"},{"key":"8444_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/COC.0b013e3180337792","volume":"30","author":"V Papantoniou","year":"2007","unstructured":"Papantoniou V, Tsiouris S, Sotiropoulou M, Valsamaki P, Koutsikos J, Ptohis N, et al. The potential role of Calcitonin Gene-Related Peptide (CGRP) in breast carcinogenesis and its correlation with 99mTc-(V)DMSA scintimammography. Am J Clin Oncol. 2007;30:420\u20137.","journal-title":"Am J Clin Oncol"},{"key":"8444_CR25","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0800767105","volume":"105","author":"M Toda","year":"2008","unstructured":"Toda M, Suzuki T, Hosono K, Hayashi I, Hashiba S, Onuma Y, et al. Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc Natl Acad Sci U S A. 2008;105:13550\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8444_CR26","doi-asserted-by":"publisher","first-page":"170423","DOI":"10.1016\/j.peptides.2020.170423","volume":"135","author":"W Zhu","year":"2021","unstructured":"Zhu W, Sheng D, Shao Y, Zhang Q, Peng Y. Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment. Peptides. 2021;135:170423.","journal-title":"Peptides"},{"key":"8444_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jpain.2006.02.013","volume":"7","author":"K Nagamine","year":"2006","unstructured":"Nagamine K, Ozaki N, Shinoda M, Asai H, Nishiguchi H, Mitsudo K, et al. Mechanical allodynia and thermal hyperalgesia induced by experimental squamous cell carcinoma of the lower gingiva in rats. J Pain. 2006;7:659\u201370.","journal-title":"J Pain"},{"key":"8444_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jpain.2010.12.016","volume":"12","author":"AP Bloom","year":"2011","unstructured":"Bloom AP, Jimenez-Andrade JM, Taylor RN, Castaneda-Corral G, Kaczmarska MJ, Freeman KT, et al. Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J Pain. 2011;12:698\u2013711.","journal-title":"J Pain"},{"key":"8444_CR29","doi-asserted-by":"publisher","first-page":"14294","DOI":"10.1074\/jbc.M109661200","volume":"277","author":"JJ Mallee","year":"2002","unstructured":"Mallee JJ, Salvatore CA, LeBourdelles B, Oliver KR, Longmore J, Koblan KS, et al. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem. 2002;277:14294\u20138.","journal-title":"J Biol Chem"},{"key":"8444_CR30","doi-asserted-by":"publisher","unstructured":"Caraceni A, Shkodra M. Cancer pain assessment and classification. Cancers (Basel). 2019;11(4):510. https:\/\/doi.org\/10.3390\/cancers11040510.","DOI":"10.3390\/cancers11040510"},{"key":"8444_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 2014;32:1647\u201354.","journal-title":"J Clin Oncol"},{"key":"8444_CR32","doi-asserted-by":"publisher","unstructured":"Tu NH, Inoue K, Chen E, Anderson BM, Sawicki CM, Scheff NN, et al. Cathepsin S Evokes PAR(2)-Dependent Pain in Oral Squamous Cell Carcinoma Patients and Preclinical Mouse Models. Cancers (Basel). 2021;13(18):4697. https:\/\/doi.org\/10.3390\/cancers13184697","DOI":"10.3390\/cancers13184697"},{"key":"8444_CR33","doi-asserted-by":"publisher","first-page":"122874","DOI":"10.1016\/j.biomaterials.2024.122874","volume":"314","author":"D Bhansali","year":"2025","unstructured":"Bhansali D, Tu NH, Inoue K, Teng S, Li T, Tran HD, et al. PAR(2) on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451. Biomaterials. 2025;314:122874.","journal-title":"Biomaterials"},{"key":"8444_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10194-022-01512-x","volume":"23","author":"E Kc","year":"2022","unstructured":"Kc E, Islam J, Park YS. Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia. J Headache Pain. 2022;23:150.","journal-title":"J Headache Pain"},{"key":"8444_CR35","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/0333102418786261","volume":"39","author":"K Messlinger","year":"2019","unstructured":"Messlinger K, Russo AF. Current understanding of trigeminal ganglion structure and function in headache. Cephalalgia. 2019;39:1661\u201374.","journal-title":"Cephalalgia"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08444-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:30:12Z","timestamp":1778671812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08444-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8444"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08444-x","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and was approved by the Institutional Research Ethics Committee of Shanghai Ninth People\u2019s Hospital for studies involving humans (No.SH9H-2019-T172-2) and animals (No.SH9H-2022-A896-1). Written informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"857"}}